Design Therapeutics Inc (DSGN)
5.33
-0.09
(-1.66%)
USD |
NASDAQ |
Sep 27, 16:00
5.35
+0.02
(+0.38%)
Pre-Market: 20:00
Design Therapeutics Cash from Operations (Quarterly): -11.26M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -11.26M |
| March 31, 2024 | -12.44M |
| December 31, 2023 | -12.80M |
| September 30, 2023 | -14.53M |
| June 30, 2023 | -13.80M |
| March 31, 2023 | -17.42M |
| December 31, 2022 | -15.09M |
| September 30, 2022 | -13.90M |
| June 30, 2022 | -10.50M |
| Date | Value |
|---|---|
| March 31, 2022 | -11.83M |
| December 31, 2021 | -9.227M |
| September 30, 2021 | -8.164M |
| June 30, 2021 | -8.289M |
| March 31, 2021 | -3.697M |
| December 31, 2020 | -2.844M |
| September 30, 2020 | -1.859M |
| June 30, 2020 | -1.307M |
| March 31, 2020 | -2.659M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-17.42M
Minimum
Mar 2023
-1.307M
Maximum
Jun 2020
-9.535M
Average
-10.88M
Median
Cash from Operations (Quarterly) Benchmarks
| Biogen Inc | 625.80M |
| PTC Therapeutics Inc | -71.45M |
| Voyager Therapeutics Inc | -31.58M |
| NovaBay Pharmaceuticals Inc | -0.578M |
| Palatin Technologies Inc | -8.607M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 27.33M |
| Cash from Financing (Quarterly) | 0.229M |
| Free Cash Flow | -51.47M |
| Free Cash Flow Per Share (Quarterly) | -0.2019 |
| Free Cash Flow Yield | -17.16% |